share_log

美迪西(688202.SH):已投入使用共计超过8.5万平方米的研发办公场地

Shanghai Medicilon Inc. (688202.SH): has put into use a total of more than 0.085 million square meters of R&D office space.

Gelonghui Finance ·  Jul 15 19:49

Shanghai Medicilon Inc. (688202.SH) recently stated during an institutional investor reception that the company has put into use a total of more than 0.085 million square meters of research and development office space, located in Shanghai Zhangjiang Hi-tech Park, Chuansha Economic Park, Nanhui Medicilon New Drug Innovation Center, Hangzhou Xiaoshan District, and the research and development center in Boston, USA. The main structure of the fundraising project 'Laboratory Expansion Project of Drug Discovery, Pharmaceutical Research and Declaration Platform' has been fully capped and applied for acceptance. The 'Medicilon North Shanghai Biomedical R&D Innovation Industrial Base Project' has also officially started construction. Future construction of the fundraising project will be steadily promoted based on the company's global strategy and business development.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment